Market Overview:
The global rheumatoid arthritis diagnosis tests market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of rheumatoid arthritis, rising awareness about early diagnosis and treatment, and technological advancements in diagnostic tests. The serology tests segment is expected to account for the largest share of the global rheumatoid arthritis diagnosis tests market in 2018. This segment is mainly driven by the increasing demand for accurate and rapid diagnostic tests for early detection of RA. The monitoring RA treatment efficiency tests segment is projected to grow at a higher CAGR during the forecast period owing to growing demand for efficient methods to monitor RA treatment efficacy. On the basis of application, diagnostic laboratories are estimated to account for the largest share of the global rheumatoid arthritis diagnosis test market in 2018 followed by ambulatory surgical centers and hospitals respectively.
Product Definition:
Rheumatoid arthritis is a type of autoimmune disorder that can cause inflammation and pain in the joints. It is typically diagnosed through a combination of medical history, physical examination, and laboratory tests. Some common laboratory tests used to diagnose rheumatoid arthritis include blood counts, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), rheumatoid factor (RF), and antinuclear antibodies (ANA). These tests help to determine whether someone has rheumatoid arthritis and how severe their condition may be.
Serology Tests:
A serology test is a medical procedure that determines the presence of an autoimmune disorder by measuring antibodies in the blood. The most common tests are rheumatoid arthritis, psoriasis, lupus and diabetes.
Serology Test Market Size, Share & Trends Analysis Report By Type (Instruments/Reagents), By Application (Diagnostic Tests), And Segment Forecasts, 2019 - 2026 -> The global serology tests market size was valued at USD 2.
Monitoring RA Treatment Efficiency Tests:
The global Monitoring RA Treatment Efficiency Tests and it's usage in Rheumatoid Arthritis Diagnosis (MRTE) market size was valued at USD 745.0 million in 2017. It is expected to expand at a CAGR of XX% during the forecast period, driven by increasing prevalence of rheumatoid arthritis and other autoimmune diseases globally coupled with launch of novel drugs for treatment of this condition.
Application Insights:
The diagnostic laboratories segment dominated the global market in 2017. This can be attributed to factors such as an increase in prevalence of rheumatoid arthritis and rise in demand for faster, accurate and sensitive diagnosis methods. Increasing number of R&D initiatives by various companies to develop advanced testing methods is also a key contributing factor towards segment growth. For instance, In April 2018, Quest Diagnostics acquired Med Fusion LLC for approximately USD 80 million to enter into blood tests market for inflammatory diseases including rheumatoid arthritis.
In 2016, Ambuulatory surgical centers accounted for the second-largest revenue share owing to factors such as an increase in patients suffering from joint pain seeking medical consultation and rising awareness about knee replacement procedures among geriatric population groups across the globe.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure, and high adoption rate for new technologies are some of the factors responsible for its large share. Moreover, increasing prevalence of rheumatoid arthritis is also expected to contribute towards regional growth over the forecast period. For instance, according to a study published by National Institute of Health (NIH), around 6 million adults were diagnosed with active rheumatoid arthritis in U.S.
Asia Pacific region is anticipated witness lucrative growth during the forecast period owing rising awareness about early diagnosis coupled with government initiatives & fundings aimed at improving healthcare facilities across emerging countries such as India & China.
Growth Factors:
- Increasing incidence of rheumatoid arthritis
- Growing awareness about rheumatoid arthritis and its diagnosis tests
- Rising demand for early diagnosis of rheumatoid arthritis for better treatment outcomes
- Technological advancements in diagnostic tests for rheumatoid arthritis
- Growing number of research studies on rheumatoid arthritis
Scope Of The Report
Report Attributes
Report Details
Report Title
Rheumatoid Arthritis Diagnosis Tests Market Research Report
By Type
Serology Tests, Monitoring RA Treatment Efficiency Tests
By Application
Diagnostic Laboratories, Ambulatory Surgical Centers, Hospitals
By Companies
Abbott, Beckman Coulter, Euro Diagnostica, Roche, Qiagen, Siemens Healthcare, Thermo Fisher Scientific, Bio Rad Laboratories, Aviva Systems Biology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Rheumatoid Arthritis Diagnosis Tests Market Report Segments:
The global Rheumatoid Arthritis Diagnosis Tests market is segmented on the basis of:
Types
Serology Tests, Monitoring RA Treatment Efficiency Tests
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostic Laboratories, Ambulatory Surgical Centers, Hospitals
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Beckman Coulter
- Euro Diagnostica
- Roche
- Qiagen
- Siemens Healthcare
- Thermo Fisher Scientific
- Bio Rad Laboratories
- Aviva Systems Biology
Highlights of The Rheumatoid Arthritis Diagnosis Tests Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Serology Tests
- Monitoring RA Treatment Efficiency Tests
- By Application:
- Diagnostic Laboratories
- Ambulatory Surgical Centers
- Hospitals
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Rheumatoid Arthritis Diagnosis Tests Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Rheumatoid arthritis diagnosis tests are used to determine if a person has the disease. Tests may include blood tests, X-rays, and scans.
Some of the major companies in the rheumatoid arthritis diagnosis tests market are Abbott, Beckman Coulter, Euro Diagnostica, Roche, Qiagen, Siemens Healthcare, Thermo Fisher Scientific, Bio Rad Laboratories, Aviva Systems Biology.
The rheumatoid arthritis diagnosis tests market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Rheumatoid Arthritis Diagnosis Tests Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Rheumatoid Arthritis Diagnosis Tests Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Rheumatoid Arthritis Diagnosis Tests Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Rheumatoid Arthritis Diagnosis Tests Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Rheumatoid Arthritis Diagnosis Tests Market Size & Forecast, 2020-2028
4.5.1 Rheumatoid Arthritis Diagnosis Tests Market Size and Y-o-Y Growth
4.5.2 Rheumatoid Arthritis Diagnosis Tests Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Serology Tests
5.2.2 Monitoring RA Treatment Efficiency Tests
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Diagnostic Laboratories
6.2.2 Ambulatory Surgical Centers
6.2.3 Hospitals
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Rheumatoid Arthritis Diagnosis Tests Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Rheumatoid Arthritis Diagnosis Tests Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Serology Tests
9.6.2 Monitoring RA Treatment Efficiency Tests
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Diagnostic Laboratories
9.10.2 Ambulatory Surgical Centers
9.10.3 Hospitals
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Serology Tests
10.6.2 Monitoring RA Treatment Efficiency Tests
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Diagnostic Laboratories
10.10.2 Ambulatory Surgical Centers
10.10.3 Hospitals
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Serology Tests
11.6.2 Monitoring RA Treatment Efficiency Tests
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Diagnostic Laboratories
11.10.2 Ambulatory Surgical Centers
11.10.3 Hospitals
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Serology Tests
12.6.2 Monitoring RA Treatment Efficiency Tests
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Diagnostic Laboratories
12.10.2 Ambulatory Surgical Centers
12.10.3 Hospitals
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Serology Tests
13.6.2 Monitoring RA Treatment Efficiency Tests
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Diagnostic Laboratories
13.10.2 Ambulatory Surgical Centers
13.10.3 Hospitals
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Rheumatoid Arthritis Diagnosis Tests Market: Competitive Dashboard
14.2 Global Rheumatoid Arthritis Diagnosis Tests Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Beckman Coulter
14.3.3 Euro Diagnostica
14.3.4 Roche
14.3.5 Qiagen
14.3.6 Siemens Healthcare
14.3.7 Thermo Fisher Scientific
14.3.8 Bio Rad Laboratories
14.3.9 Aviva Systems Biology
